Compare Stocks: BIOL, VRAX, BTCY, and TNON

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BIOL BIOLASE		$0.00	$0.02 ▼ $1.94	$581K	0.67	2.58 million shs	N/A
BTCY Biotricity	$0.12 -1.7%	$0.12	$0.09 ▼ $0.75	$2.35M	1.13	55,358 shs	1,005 shs
TNON Tenon Medical	$5.16 -13.4%	$10.95	$4.38 ▼ $54.95	$2.02M	1.39	62,164 shs	34,054 shs
VRAX Virax Biolabs Group	$2.86 +1.4%	$3.59	$2.50 ▼ $21.75	$2.25M	1.35	122,342 shs	50,709 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BIOL BIOLASE	0.00%	0.00%	0.00%	0.00%	-80.00%
BTCY Biotricity	-1.69%	+10.48%	-3.33%	-37.50%	-78.52%
TNON Tenon Medical	-13.42%	+12.54%	-26.94%	-79.15%	-91.17%
VRAX Virax Biolabs Group	+1.42%	-4.03%	-17.10%	-25.47%	-84.75%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BIOL BIOLASE		$0.00	$0.02 ▼ $1.94	$581K	0.67	2.58 million shs	N/A
BTCY Biotricity	$0.12 -1.7%	$0.12	$0.09 ▼ $0.75	$2.35M	1.13	55,358 shs	1,005 shs
TNON Tenon Medical	$5.16 -13.4%	$10.95	$4.38 ▼ $54.95	$2.02M	1.39	62,164 shs	34,054 shs
VRAX Virax Biolabs Group	$2.86 +1.4%	$3.59	$2.50 ▼ $21.75	$2.25M	1.35	122,342 shs	50,709 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BIOL BIOLASE	0.00%	0.00%	0.00%	0.00%	-80.00%
BTCY Biotricity	-1.69%	+10.48%	-3.33%	-37.50%	-78.52%
TNON Tenon Medical	-13.42%	+12.54%	-26.94%	-79.15%	-91.17%
VRAX Virax Biolabs Group	+1.42%	-4.03%	-17.10%	-25.47%	-84.75%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BIOL BIOLASE	0.00	N/A	N/A	N/A
BTCY Biotricity	0.00	N/A	N/A	N/A
TNON Tenon Medical	2.00	Hold	N/A	N/A
VRAX Virax Biolabs Group	2.00	Hold	$25.00	774.13% Upside

Current Analyst Ratings Breakdown

Latest BIOL, VRAX, BTCY, and TNON Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
7/17/2026	TNON Tenon Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/6/2026	VRAX Virax Biolabs Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 8/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BIOL BIOLASE	$48.83M	0.00	N/A	N/A	($0.07) per share	0.00
BTCY Biotricity	$12.06M	0.19	N/A	N/A	($1.30) per share	-0.09
TNON Tenon Medical	$3.94M	0.45	N/A	N/A	$6.19 per share	0.83
VRAX Virax Biolabs Group	$10K	228.80	N/A	N/A	$42.23 per share	0.07

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BIOL BIOLASE	-$20.63M	-$14.94	N/A	N/A	N/A	-41.65%	-1,782.73%	-55.31%	N/A
BTCY Biotricity	-$14.09M	-$0.12	N/A	N/A	N/A	-80.42%	N/A	-188.47%	N/A
TNON Tenon Medical	-$12.56M	-$45.10	N/A	N/A	N/A	-257.85%	-1,636.44%	-120.98%	N/A
VRAX Virax Biolabs Group	-$5.02M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest BIOL, VRAX, BTCY, and TNON Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/13/2026	Q2 2026	TNON Tenon Medical	-$8.40	-$12.35	-$3.95	-$12.35	$1.54 million	$1.28 million
7/3/2026	Q4 2026	VRAX Virax Biolabs Group	-$1.75	-$0.1950	+$1.5550	-$0.1950	$0.00 million	$0.01 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BIOL BIOLASE	N/A	N/A	N/A	N/A	N/A
BTCY Biotricity	N/A	N/A	N/A	N/A	N/A
TNON Tenon Medical	N/A	N/A	N/A	N/A	N/A
VRAX Virax Biolabs Group	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BIOL BIOLASE	N/A	0.71	0.36
BTCY Biotricity	N/A	0.23	0.10
TNON Tenon Medical	N/A	1.03	0.92
VRAX Virax Biolabs Group	N/A	9.97	9.97

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BIOL BIOLASE	8.79%
BTCY Biotricity	3.89%
TNON Tenon Medical	22.74%
VRAX Virax Biolabs Group	8.61%

Insider Ownership

Company	Insider Ownership
BIOL BIOLASE	0.27%
BTCY Biotricity	1.60%
TNON Tenon Medical	17.71%
VRAX Virax Biolabs Group	45.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BIOL BIOLASE	160	33.41 million	33.32 million	Not Optionable
BTCY Biotricity	40	20.24 million	22.08 million	No Data
TNON Tenon Medical	8	340,000	279,000	Not Optionable
VRAX Virax Biolabs Group	5	800,000	438,000	Not Optionable

BIOL, VRAX, BTCY, and TNON Headlines

Recent News About These Companies

Virax Biolabs Calls August 14 EGM to Approve Major Share Capital Increase

August 2, 2026 | theglobeandmail.com

RedChip Companies, Inc.: Alliance Entertainment and Virax Interviews Aired on the RedChip Small Stocks, Big Money Show on Bloomberg TV

July 20, 2026 | finanznachrichten.de

Virax Biolabs Boosts Liquidity, Secures Fosun Deal and Restores Nasdaq Compliance After Fiscal 2026 Report

July 17, 2026 | tipranks.com

Virax BioLabs Group Limited: Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement

July 16, 2026 | finanznachrichten.de

Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement

July 16, 2026 | prnewswire.com

Virax Biolabs Raises $3.3 Million via Exercise of Investment Options and Issues New Warrants

July 10, 2026 | tipranks.com

Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

July 10, 2026 | prnewswire.com

Virax Biolabs Group Limited Ordinary Shares (VRAX) Institutional Holdings

July 10, 2026 | nasdaq.com

Virax Biolabs stock skyrockets 100% on exclusive distribution agreement

July 9, 2026 | msn.com

Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

July 9, 2026 | prnewswire.com

Virax Biolabs shares double after exclusive Fosun distribution agreement (VRAX)

July 9, 2026 | msn.com

Why this biotech stock more than tripled on Thursday

July 9, 2026 | invezz.comI

Virax Biolabs Jumps on Fosun Diagnostics Supply Agreement

July 9, 2026 | quiverquant.comQ

Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics

July 9, 2026 | prnewswire.com

Virax Biolabs Group announces 1-for-25 share consolidation

June 25, 2026 | msn.com

Virax Biolabs Approves 1-for-25 Share Consolidation to Maintain Nasdaq Listing

June 24, 2026 | tipranks.com

Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation

June 24, 2026 | prnewswire.com

Virax BioLabs Group Limited: Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune in Long COVID and Related Post-Acute Infection Syndromes

May 26, 2026 | finanznachrichten.de

Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes

May 26, 2026 | prnewswire.com

Virax Biolabs Calls June 5 EGM to Approve Reverse Share Split and Charter Amendments

May 22, 2026 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIOL, VRAX, BTCY, and TNON Company Descriptions

BIOLASE NASDAQ:BIOL

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Biotricity NASDAQ:BTCY

$0.12 0.00 (-1.69%)

As of 08/14/2026 01:38 PM Eastern

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Tenon Medical NASDAQ:TNON

$5.16 -0.80 (-13.42%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$5.32 +0.17 (+3.20%)

As of 08/14/2026 07:34 PM Eastern

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

Virax Biolabs Group NASDAQ:VRAX

$2.86 +0.04 (+1.42%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$2.80 -0.05 (-1.92%)

As of 08/14/2026 07:54 PM Eastern

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name. It also develops T-Cell IVD test kit for COVID-19, which intend to adapt for immunological profiling against multiple viral threats under the ViraxImmune Brand, as well as a proprietary mobile application for ViraxImmune that presents an individual's immunological profiling data and provide advice on the users' immune system. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, pharmaceutical companies, research institutions, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was incorporated in 2021 and is headquartered in London, the United Kingdom.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BIOL, VRAX, BTCY, and TNON Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BIOL, VRAX, BTCY, and TNON Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BIOL, VRAX, BTCY, and TNON Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIOL, VRAX, BTCY, and TNON Company Descriptions

BIOLASE NASDAQ:BIOL

Biotricity NASDAQ:BTCY

Tenon Medical NASDAQ:TNON

Virax Biolabs Group NASDAQ:VRAX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BIOL, VRAX, BTCY, and TNON Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BIOL, VRAX, BTCY, and TNON Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BIOL, VRAX, BTCY, and TNON Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIOL, VRAX, BTCY, and TNON Company Descriptions

BIOLASE NASDAQ:BIOL

Biotricity NASDAQ:BTCY

Tenon Medical NASDAQ:TNON

Virax Biolabs Group NASDAQ:VRAX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools